Alphagan and Hydroxyzine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Alphagan (brimonidine tartrate) and Hydroxyzine (hydroxyzine hydrochloride). Common drug interactions include dyspnoea among females and pain among males.

The phase IV clinical study analyzes what interactions people have when they take Alphagan and Hydroxyzine. It is created by eHealthMe based on reports of 72 people who take the same drugs from the FDA, and is updated regularly.

What is Alphagan?

Alphagan has active ingredients of brimonidine tartrate. It is often used in glaucoma. eHealthMe is studying from 9,981 Alphagan users. Check the latest studies of Alphagan.

What is Hydroxyzine?

Hydroxyzine has active ingredients of hydroxyzine hydrochloride. It is often used in stress and anxiety. eHealthMe is studying from 54,069 Hydroxyzine users. Check the latest studies of Hydroxyzine.



On Jul, 15, 2026

72 people who take Alphagan and Hydroxyzine together, and have interactions are studied.

Alphagan and Hydroxyzine drug interactions.

What are the common drug interactions of Alphagan and Hydroxyzine, by gender? *:

female:

  1. Dyspnoea (difficult or laboured respiration)
  2. Fall
  3. Fatigue (feeling of tiredness)
  4. Urticaria (rash of round, red welts on the skin that itch intensely)
  5. Abdominal pain
  6. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Blindness unilateral
  9. Blood pressure increased
  10. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)

male:

  1. Pain
  2. Dizziness
  3. Dehydration (dryness resulting from the removal of water)
  4. Diarrhoea
  5. Nausea (feeling of having an urge to vomit)
  6. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  7. Asthenia (weakness)
  8. Chondropathy (disease of the cartilage)
  9. Emotional distress
  10. Essential hypertension (primary hypertension)

What are the common drug interactions of Alphagan and Hydroxyzine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Dyspnoea (difficult or laboured respiration)
  2. Respiratory tract congestion (blockage on respiratory system)
  3. Abdominal pain
  4. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  5. Cerebrovascular disorder (disease of brain)
  6. Chest pain
  7. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  8. Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)
  9. Fibromyalgia (a long-term condition which causes pain all over the body)
  10. Gastrointestinal pain

50-59:

  1. Joint swelling
  2. Oxygen saturation decreased
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Bone density decreased
  5. Bone loss
  6. Chondropathy (disease of the cartilage)
  7. Emotional distress
  8. Gait disturbance
  9. Muscle atrophy (a decrease in the mass of the muscle)
  10. Osteoarthritis (a joint disease caused by cartilage loss in a joint)

60+:

  1. Chronic kidney disease
  2. Fall
  3. Arrhythmia (irregular heartbeat)
  4. Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)
  5. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
  6. Chest pain
  7. Disease recurrence
  8. Dyspnoea (difficult or laboured respiration)
  9. Erythema (redness of the skin)
  10. Gastric disorder (disease of stomach)

What are the existing conditions these people have? *

  1. High Blood Pressure: 11 people, 15.28%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 10 people, 13.89%
  3. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 9 people, 12.50%
  4. Cardiac Disorder: 9 people, 12.50%
  5. Multiple Myeloma (cancer of the plasma cells): 7 people, 9.72%
  6. Hiv Infection: 7 people, 9.72%
  7. Pain: 6 people, 8.33%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 8.33%
  9. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 5 people, 6.94%
  10. Itching: 4 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Alphagan and Hydroxyzine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Alphagan and Hydroxyzine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Alphagan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Hydroxyzine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Alphagan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hydroxyzine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on brimonidine tartrate and hydroxyzine hydrochloride (the active ingredients of Alphagan and Hydroxyzine, respectively), and Alphagan and Hydroxyzine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: